The Treatment of Glabellar Frown Lines
Completed · Phase 4
Conditions studied: Glabellar Frown Lines
In brief
The purpose of this study is to show that two FDA-approved botulinum toxin drugs called Xeomin® and Botox® can reduce the severity of vertical lines (wrinkles) that appear between the eyebrows (glabellar frown lines).
Key facts
- Study ID
- NCT02096081
- Run by
- Merz North America, Inc.
- People needed
- 250
- Starts
- 2014-02-01
- Expected to finish
- 2014-11-01
- Last updated by the study team
- 2017-10-19
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Outpatient females 18 to 50 years of age
- Moderate to severe glabellar frown lines
You may not qualify if…
- Glabellar Frown Lines at rest rating 3 on the 4-point Facial Wrinkle Scale
- Previous treatment with botulinum toxin
- Previous treatment with biodegradable fillers in glabellar area within last 12 months
- Any severe or uncontrolled systemic disease, malignant tumor, or medical history of HIV infection
- Known hypersensitivity to incobotulinumtoxinA or onabotulinumtoxinA or to any of their excipients
- Intake of any of the forbidden concomitant medication or other agents that might interfere with neuromuscular function or might interfere with the action of botulinum toxin type within 14 days prior to injection
Where it is running
- Merz Investigative Site #001099 — Los Angeles, California, United States
- Merz Investigative Site #001300 — Sacramento, California, United States
- Merz Investigative Site #001299 — Santa Monica, California, United States
- Merz Investigative Site #001298 — Washington D.C., District of Columbia, United States
- Merz Investigative Site #001170 — Washington D.C., District of Columbia, United States
- Merz Investigative Site #001101 — Coral Gables, Florida, United States
- Merz Investigative Site #001105 — Metairie, Louisiana, United States
- Merz Investigative Site #001098 — Chestnut Hill, Massachusetts, United States
- Merz Investigative Site #001297 — New York, New York, United States
- Merz Investigative Site #001097 — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.